boardpipelinepipelinesollpurablisibimodpublicationsclinical studiesclinical studiessolutionsimplicitychablis sc1chablis 7 5bright scfor investorscorporate profileevents & presentationspress releasesanalyst coveragestock informationcorporate governancefinancials & filingsinvestor contactcontact us about usabout usmanagementboard of directorsscientific advisory boardpipelinepipelinesollpurablisibimodpublicationsclinical studiesclinical studiessolutionsimplicitychablis sc1chablis 7 5bright scfor investorscorporate profileevents & presentationspress releasesanalyst coveragestock informationcorporate governancefinancials & filingsinvestor contactcontact us right patientright therapylearn about anthera s development program for the treatment of systemic lupus erythematosuslearn moreworking for the end ofburdensomeepi treatmentslearn about anthera s developmental next generation pancreatic enzyme replacement therapylearn morea new path foriga nephropathypatientslearn how anthera pharmaceuticals is developing the world s first therapy to address the root cause of iganlearn more anthera homepage siteadministrator 2016 09 08t05 32 33 00 00 anthera pharmaceuticals we are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs . find out more about what we are doing for patients with cystic fibrosis systemic lupus erythematosus and iga nephropathy cystic fibrosissystemic lupus erythematosusigananth on nasdaq latest newsanthera pharmaceuticals announces direct registered offering . read more anthera pharmaceuticals announces appointment of dr. william shanahan jr. as chief medical officer . read more upcoming eventsciti 11th annual biotech conference september 7 2016 anthera pharmaceuticals inc. 25801 industrial blvd suite b hayward ca 94545 privacy policy i legal policy copyright 2016 anthera all rights reserved facebooktwitterlinkedin